Key result
This review discusses the spectrum of vascular abnormalities and treatment options for systemic sclerosis, highlighting the potential modulatory role of lysophospholipids in disease pathogenesis.
This review summarizes current understanding and treatment options for vascular manifestations in systemic sclerosis, highlighting potential novel pathways involving lysophospholipids.
No takes yet. Share an insight, caveat, or question.
No change to systemic sclerosis vasculopathy management; leaves open lysophospholipid modulation as hypothesis-generating research target.
Postlethwaite et al. (2011) conducted a review in Systemic sclerosis (SSc). This review discusses the spectrum of vascular abnormalities and treatment options for systemic sclerosis, highlighting the potential modulatory role of lysophospholipids in disease pathogenesis.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: